Loading...
XNYS
IFF
Market cap20bUSD
Jun 10, Last price  
79.33USD
1D
1.45%
1Q
-0.28%
Jan 2017
-32.67%
Name

International Flavors & Fragrances Inc

Chart & Performance

D1W1MN
P/E
83.51
P/S
1.77
EPS
0.95
Div Yield, %
1.51%
Shrs. gr., 5y
17.71%
Rev. gr., 5y
17.44%
Revenues
11.48b
+0.04%
1,993,393,0002,095,390,0002,276,638,0002,389,372,0002,326,158,0002,622,862,0002,788,018,0002,821,446,0002,952,896,0003,088,533,0003,023,189,0003,116,350,0003,398,719,0003,977,539,0005,140,084,0005,084,239,00011,656,000,00012,440,000,00011,479,000,00011,484,000,000
Net income
243m
P
193,066,000226,500,000247,128,000229,628,000195,526,000263,557,000266,866,000254,134,000353,544,000414,543,000411,665,000405,031,000295,665,000337,302,000455,873,000365,000,000268,000,000-1,836,000,000-2,565,000,000243,000,000
CFO
1.07b
-25.64%
177,160,000262,901,000314,062,000232,515,000291,637,000315,136,000189,190,000333,079,000407,562,000518,390,000433,578,000535,406,000390,756,000436,704,000698,965,000714,098,0001,437,000,000345,000,0001,439,000,0001,070,000,000
Dividend
Sep 20, 20240.4 USD/sh
Earnings
Aug 04, 2025

Profile

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
IPO date
Mar 02, 1964
Employees
24,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11,484,000
0.04%
11,479,000
-7.73%
12,440,000
6.73%
Cost of revenue
8,031,000
8,434,000
8,892,000
Unusual Expense (Income)
NOPBT
3,453,000
3,045,000
3,548,000
NOPBT Margin
30.07%
26.53%
28.52%
Operating Taxes
31,000
45,000
211,000
Tax Rate
0.90%
1.48%
5.95%
NOPAT
3,422,000
3,000,000
3,337,000
Net income
243,000
-109.47%
(2,565,000)
39.71%
(1,836,000)
-785.07%
Dividends
(514,000)
(826,000)
(810,000)
Dividend yield
2.37%
4.00%
3.03%
Proceeds from repurchase of equity
(13,000)
(21,000)
BB yield
0.06%
0.08%
Debt
Debt current
1,413,000
970,000
597,000
Long-term debt
8,632,000
10,555,000
11,024,000
Deferred revenue
18,000
Other long-term liabilities
733,000
813,000
1,221,000
Net debt
9,566,000
10,811,000
11,118,000
Cash flow
Cash from operating activities
1,070,000
1,439,000
345,000
CAPEX
(463,000)
(503,000)
(506,000)
Cash from investing activities
326,000
574,000
745,000
Cash from financing activities
(1,606,000)
(1,851,000)
(1,182,000)
FCF
2,262,000
3,056,000
2,975,000
Balance
Cash
469,000
703,000
493,000
Long term investments
10,000
11,000
10,000
Excess cash
140,050
Stockholders' equity
(5,062,000)
(4,269,000)
(1,120,000)
Invested Capital
29,217,000
30,522,000
30,726,000
ROIC
11.46%
9.80%
10.34%
ROCE
13.41%
10.80%
11.13%
EV
Common stock shares outstanding
256,000
255,000
255,000
Price
84.55
4.42%
80.97
-22.77%
104.84
-30.41%
Market cap
21,644,800
4.83%
20,647,350
-22.77%
26,734,200
-26.97%
EV
31,245,800
31,489,350
37,911,200
EBITDA
4,468,000
4,187,000
4,727,000
EV/EBITDA
6.99
7.52
8.02
Interest
305,000
380,000
336,000
Interest/NOPBT
8.83%
12.48%
9.47%